Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;89(1):54-65.
doi: 10.1002/ana.25918. Epub 2020 Oct 15.

Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome

Collaborators, Affiliations

Causal Associations Between Modifiable Risk Factors and the Alzheimer's Phenome

Shea J Andrews et al. Ann Neurol. 2021 Jan.

Abstract

Objective: The purpose of this study was to infer causal relationships between 22 previously reported risk factors for Alzheimer's disease (AD) and the "AD phenome": AD, AD age of onset (AAOS), hippocampal volume, cortical surface area and thickness, cerebrospinal fluid (CSF) levels of amyloid-β (Aβ42 ), tau, and ptau181 , and the neuropathological burden of neuritic plaques, neurofibrillary tangles (NFTs), and vascular brain injury (VBI).

Methods: Polygenic risk scores (PRS) for the 22 risk factors were computed in 26,431 AD cases/controls and the association with AD was evaluated using logistic regression. Two-sample Mendelian randomization (MR) was used to infer the causal effect of risk factors on the AD phenome.

Results: PRS for increased education and diastolic blood pressure were associated with reduced risk for AD. MR indicated that only education was causally associated with reduced risk of AD, delayed AAOS, and increased cortical surface area and thickness. Total- and LDL-cholesterol levels were causally associated with increased neuritic plaque burden, although the effects were driven by single nucleotide polymorphisms (SNPs) within the APOE locus. Diastolic blood pressure and pulse pressure are causally associated with increased risk of VBI. Furthermore, total cholesterol was associated with decreased hippocampal volume; smoking initiation with decreased cortical thickness; type 2 diabetes with an earlier AAOS; and sleep duration with increased cortical thickness.

Interpretation: Our comprehensive examination of the genetic evidence for the causal relationships between previously reported risk factors in AD using PRS and MR supports a causal role for education, blood pressure, cholesterol levels, smoking, and diabetes with the AD phenome. ANN NEUROL 2021;89:54-65.

PubMed Disclaimer

Conflict of interest statement

Potential Conflicts of Interest

S.J.A., B.F.H., E.M., P.F.O., and A.M.G. have no conflicts of interest to declare.

Figures

FIGURE:
FIGURE:
Putative causal associations between modifiable risk factors and the AD phenome. Shown are the best IVW results for each causal association, with colors representing the standardized effect sizes - for LOAD, NP, NFT, and AAOS red indicates increased risk / earlier onset and blue reduced risk / delayed onset, for CSF levels and Hippocampal volume, red indicates increased levels / volume and blue reduced levels / volume. . FDR < 0.1; * FDR < 0.05; ** FDR < 0.01; *** FDR < 0.001. Causal estimates bracketed in red or orange indicate significant causal effects that showed no evidence for horizontal pleiotropy or where sensitivity analyses were also significant. AAOS = Alzheimers disease age of onset; AD = Alzheimers disease; AUDIT = alcohol use disorder identification test; BMI = body mass index; CSF = cerebrospinal fluid; FDR = false discovery rate; IVW = inverse-variance weighted; NFT = neurofibrillary tangle; NP = neuritic plaque; PA = physical activity. [Color figure can be viewed at www.annalsofneurology.org]

References

    1. Alzheimer’s Association. 2020 Alzheimer’s disease facts and figures. Alzheimer’s Dement 2020;16:391–460.
    1. Anstey KJ, Ee N, Eramudugolla R, et al. A systematic review of meta-analyses that evaluate risk factors for dementia to evaluate the quantity, quality, and global representativeness of evidence. J Alzheimers Dis 2019;70:S165–S186. - PMC - PubMed
    1. Livingston G, Sommerlad A, Orgeta V, et al. Dementia prevention, intervention, and care. Lancet 2017;390:2673–2734. - PubMed
    1. Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020;396:413–446. - PMC - PubMed
    1. World Health Organization, Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines 2019. - PubMed

Publication types

MeSH terms